Company Overview and News

 
And The Dividend Flow Turned Into A Flood, Part II

2018-01-16 seekingalpha
In a look at another 21 companies across seven different market sectors, debt continues to weigh heavily in each of their respective profiles.
Upvote Downvote

 
'Safer' Dividend S&P SmallCap600 Dogs Led By Big 5 And TiVo 1-Year Net Gains Of September Analysts

2017-09-28 seekingalpha
21 of 65 S&P SmallCap600 Index top-yield dividend payouts were deemed "safer" because they showed positive one-year returns and free cash-flow yields greater than their dividend yields as of 9/22/17.
Upvote Downvote

 
Safety Insurance Group Earnings: Low Losses Mean Larger Dividends

2017-08-03 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Hate Checking Your Portfolio? Try These 3 Stocks

2017-06-05 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
How the Insurance Industry Makes Money

2017-05-31 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
How Insurance Companies Work

2017-05-30 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Safety Insurance Group Drives Through Its First Quarter With an Underwriting Profit

2017-05-05 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

 
Safety Insurance Group Drives Safely Through the 4th Quarter

2017-02-24 fool
Safety Insurance Group (NASDAQ:SAFT) reported net income of $12 million in the fourth quarter, a 17% increase from the year-ago period. Higher earnings were the result of lower insurance losses in what is normally a seasonally poor period for the company.
Upvote Downvote

 
Safety Insurance Group Drives on to 55% Higher Earnings

2016-11-07 fool
The winter storms that led to uncharacteristically poor results for Safety Insurance Group's (NASDAQ:SAFT) in 2015 are firmly in the rearview mirror in the third quarter of 2016. The company recently reported third-quarter earnings of $18.6 million, a 55% increase over the year-ago period, helped by broad rate increases and an improved loss ratio.
Upvote Downvote

 
General Electric's Impressive Entry into the Grid Based Energy Storage Business

2016-09-19 seekingalpha
I've been writing about the rapidly evolving market for manufactured energy storage devices in grid-based applications since last August when I published Grid-based Energy Storage: Birth of a Giant. At the time, only a handful of smaller public companies were working on grid-based storage solutions including Maxwell Technologies (MXWL), Beacon Power (BCON), Altair Nanotechnologies (ALTI), Active Power (ACPW) and Axion Power International (AXPW.
Upvote Downvote

 
Next-Generation Military Battery Suppliers Are Fully Charged

2016-09-18 seekingalpha
Modern soldiers have been referred to as "Energizer Bunnies" because they are significantly weighed down by large numbers of heavy batteries. This has created huge opportunities to bring new technologies that are low-weight, high density and high efficiency into the military space. Batteries are considered mission critical in military applications and must meet extreme military specifications.
Upvote Downvote

 
Safety Insurance Group: Trading At Near-High, But Worth Considering

2016-09-18 seekingalpha
On August 3, Safety Insurance Group, Inc. (NASDAQ:SAFT) posted Q2 EPS of $1.41, beating estimates by $0.29. They also reported net earned premiums of $187.39 million, beating estimates by $0.49 million. On the same date, they declared a quarterly dividend of $0.70, which was paid on September 15.
Upvote Downvote

 
5 Dividend Paying Companies With No, Or Very Little Debt (Part 3)

2016-09-18 seekingalpha
We will take another look at five more companies that pay a dividend and currently have little or no debt on their balance sheet.
Upvote Downvote

 
Top 20 Insurance Stocks For Dividend Growth Investors

2016-09-17 seekingalpha
The dividend yields on insurance stocks have a fairly large range and some look like much better fits for dividend growth investors.
Upvote Downvote

 
Price Increases Boost Safety Insurance Group's Second-Quarter Earnings

2016-08-10 fool
Safety Insurance Group (NASDAQ:SAFT) saw its net income rise in the second quarter as its results were helped by lower losses and higher premiums per written exposure in its core commercial auto and homeowners lines of insurance.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...